LEONHARDT HARRY J
SEC insider (Form 3/4/5 filer). CIK 0001286102. GC & Chief Compliance Officer at Poseida Therapeutics, Inc. (PSTX). 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 8, 2025. Located in SAN DIEGO, CA.
Companies LEONHARDT HARRY J has filed insider reports for
- Poseida Therapeutics, Inc. (PSTX): Officer, GC & Chief Compliance Officer
LEONHARDT HARRY J
CIK: 0001286102
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Poseida Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Tender OfferDirect223.6K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
160.4K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
137K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
72.6K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
125.3K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
111.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Tender Offer | 223,640 | - | $0 | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 160,385 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 137,000 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 72,568 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 125,283 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 111,700 | - | - | Direct |
1-6 of 6 transactions